Pharma Journalist -

CAMP4 Therapeutics announced a research collaboration with Alnylam Pharmaceuticals focused on identifying new druggable targets to address an undisclosed rare disease of the liver with…
Read More...

B-MoGen Biotechnologies and CytoSen Therapeutics announced a research collaboration to develop the next generation of gene-modified Natural Killer Cell (NK) therapies. B-MoGen will…
Read More...

BioNTech AG, a rapidly growing biotechnology company developing precise and individualized immunotherapies for the treatment of cancer and the prevention of infectious diseases, and MAB…
Read More...

SMi is proud to announce the 3rd Annual 3D Cell Culture conference is returning to London in just four weeks’ time. Over the past few years, 3D Cell Culture has gained momentum…
Read More...

PeptiDream announced that it has entered into a multi-program collaborative research agreement with Osaka-based Shionogi & Co., Ltd for the discovery and development of a series of…
Read More...

Philogen announced through its wholly-owned Swiss subsidiary, Philochem AG, a collaboration agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson…
Read More...

Incyte Corporation announced that the first patient has been treated in GRAVITAS-309, a pivotal Phase 3 trial for the first-line treatment of patients with chronic graft-versus-host…
Read More...

Alvotech announced that it has successfully raised US$300 million through a private bond offering. Net proceeds from the capital raised will be used to fuel continued growth, refinance…
Read More...

Ferring Pharmaceuticals and Karolinska Institutet announced a five-year extension of their collaboration to explore the potential of the human microbiome in reproductive medicine and…
Read More...

Gamida Cell Ltd. and Be The Match BioTherapies, a subsidiary of the National Marrow Donor Program/Be The Match offering integrated platforms and software to manage the collection and…
Read More...